GleamWall
中文EN

BGMS Bio Green Med Solution, Inc.

Wholesale-Durable Goods, NEC · Nasdaq · SEC CIK 1130166 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY69.4%
TTM EPS YoY75.3%
Revenue 3-yr CAGR55.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-156.1%
Net margin-114.5%
FCF margin—
EBITDA margin-155.7%

Returns

ROE-24.2%
ROA-21.3%
ROIC (approx.)-68.7%
Asset turnover0.19x

Leverage & solvency

Liabilities / assets10.9%
Debt / equity0.00x
Current ratio6.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.57x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$454,000$336,000$743,000-$80,961$81,000——$0
R&D expense———-$47,000$5,000$68,000$822,000$880,000
SG&A expense$635,000$497,000$389,000$1.25M$1.00M$1.25M$4.21M$948,000
Operating income-$520,000-$418,000-$246,000-$1.08M-$987,000-$1.25M-$4.21M-$1.83M
Pretax income-$446,000-$396,000-$167,000$3.45M-$983,000-$1.25M-$4.21M-$1.86M
Income tax$3,000$9,000$30,000$5,000$0$2,000—$1.19M
Net income-$449,000-$405,000-$197,000-$611,000-$988,000-$1.32M-$81,000-$3.05M
EBITDA-$520,000-$418,000-$245,000-$1.08M-$987,000——-$1.83M
EPS (basic)-0.07———-1.31-0.980.00—
EPS (diluted)-0.07———-1.31-0.980.00—
Weighted avg. shares (diluted)6.62M5.60M5.46M—1.91M1.36M365,231—
Banking
Net interest income$44,000$9,000$9,000$45,000$9,000$2,000$6,000$30,000
Balance sheet
Cash & equivalents$3.45M$3.79M$3.34M$3.50M$3.84M$4.28M$3.45M$3.14M
Receivables$974,000$1.07M$1.19M$1.26M$725,000———
Inventory$991,000$972,000$947,000$1.38M$1.37M———
Current assets$5.58M$5.97M$5.62M$6.26M$6.44M$4.38M$3.71M$3.67M
PP&E, net$134,000$136,000$138,000$137,000$129,000$1,000$1,000$3,000
Goodwill$1.57M$1.57M$1.57M$1.57M$1.57M———
Total assets$7.48M$7.85M$7.56M$8.19M$8.16M$4.40M$3.73M$4.09M
Current liabilities$815,000$692,000$796,000$1.33M$1.00M$760,000$663,000$6.27M
Total liabilities$817,000$694,000$804,000$1.34M$1.06M$770,000$672,000$6.27M
Shareholders' equity$6.66M$7.16M$6.76M$6.84M$7.10M$3.63M$3.06M-$2.17M
Shares outstanding6.62M6.62M5.52M5.40M3.50M1.58M207.34M36,913
Cash flow statement
Operating cash flow-$287,000-$352,000-$278,000-$33,000-$434,000-$1.06M-$3.25M-$1.36M
Capital expenditure$0$0$1,000—————
Free cash flow-$287,000-$352,000-$279,000—————
Investing cash flow$0$0-$1,000—————
Financing cash flow-$20,000$773,000$105,000-$259,000-$3,000$1.88M$3.65M$1.61M
Depreciation & amortization$0$0$1,000$4,000$0——$1,000
Stock-based compensation$0$1,000$1,000$655,000$6,000$7,000$1.67M$93,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.